Related Experiment Video
Updated: Jun 12, 2026

09:36
Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Allergic and hypersensitivity reactions in the intensive care unit
Salmaan Kanji1, Clarence Chant
1Ottawa Hospital and Ottawa Health Research Institute, Ottawa, Ontario, Canada.
Critical Care Medicine
|May 27, 2010
Summary
Hypersensitivity reactions, immunologically based adverse drug reactions, are common in ICUs. Management focuses on withdrawal of offending agents and supportive care due to unpredictable immune responses.
Area of Science:
- Clinical Immunology
- Critical Care Medicine
- Pharmacology
Background:
- Hypersensitivity reactions are immunologically mediated adverse events to drugs or chemicals.
- These reactions are prevalent in intensive care units (ICUs), ranging from mild rashes to life-threatening anaphylaxis.
- Traditional classification (Types I-IV) has unclear clinical relevance, with new subtypes emerging.
Purpose of the Study:
- To outline the background and types of hypersensitivity reactions.
- To provide descriptions and management strategies for common hypersensitivity reactions in the ICU.
Main Methods:
- Review of existing literature on hypersensitivity reactions.
- Analysis of clinical presentations and immunological mechanisms.
- Synthesis of current management strategies, including avoidance, supportive care, and pharmacotherapy.
Main Results:
- Hypersensitivity reactions present a spectrum of severity in ICUs.
- Prevention is challenging due to the unpredictable immunological nature.
- Management relies on identifying and withdrawing the offending agent, alongside supportive and symptomatic treatments.
Conclusions:
- Effective management of hypersensitivity reactions in the ICU requires understanding their diverse presentations and underlying mechanisms.
- Current strategies emphasize supportive care and targeted interventions when specific reactions are identified.
Related Concept Videos
Allergic Reactions: Anaphylaxis
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Hypersensitivities
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Allergic Drug Reactions
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Allergic Reactions
Overview
Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Hypersensitivity Reactions: Immune-Complex Reactions
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...
